Management of Pyrethroid Poisoning
Pyrethroid poisoning requires primarily supportive care with aggressive symptomatic management, as there is no specific antidote available 1, 2.
Immediate Assessment and Stabilization
Airway Management
- Secure the airway early if there is altered mental status, seizures, or respiratory depression
- Intubate for airway protection in severe cases, particularly with Type II pyrethroid poisoning where seizures and excessive salivation are prominent 2, 3
- Monitor for delayed laryngeal edema - this can occur 8+ days after ingestion even when initial airway examination is normal, requiring extended observation and potential tracheostomy 4
Route-Specific Decontamination
Dermal exposure:
- Remove all contaminated clothing immediately
- Thoroughly wash skin with soap and water to remove residual pyrethroid bound to epidermis 2, 3
- For paraesthesia (burning/tingling sensation, especially facial): apply topical vitamin E (dl-alpha tocopherol acetate) which may reduce severity 2
Ingestion:
- Expect immediate gastrointestinal irritation: sore throat, nausea, vomiting, abdominal pain within minutes 2
- Do NOT induce vomiting
- Consider activated charcoal if presenting within 1 hour of ingestion and airway is protected
Syndrome Recognition and Treatment
Type I Pyrethroids (e.g., permethrin, allethrin)
Clinical features: Fine tremor, reflex hyperexcitability, prostration 3, 5
Type II Pyrethroids (e.g., cypermethrin, deltamethrin, fenvalerate)
Clinical features: Coarse tremor, salivation, choreoathetosis, seizures, hyperexcitability 2, 3
Seizure Management
- Benzodiazepines are first-line for seizure control
- Pentobarbitone is surprisingly effective for Type II pyrethroid poisoning when benzodiazepines fail, due to its dual action as chloride channel agonist and membrane stabilizer 3
- Standard anticonvulsants are often inadequate 3
Sympathetic Hyperactivity
- Both types produce potent sympathetic activation 3
- Manage with benzodiazepines for agitation
- Monitor for palpitations, chest tightness, hypertension
Monitoring and Complications
Timeline of Systemic Effects
- Systemic toxicity develops 4-48 hours after exposure 2
- Common: dizziness, headache, fatigue
- Less frequent: palpitations, chest tightness, blurred vision
- Life-threatening: coma and convulsions 2
Critical Monitoring Points
- Neurological status for 48+ hours post-exposure
- Upper airway for at least 2 weeks in severe ingestions due to risk of delayed laryngeal edema 4
- Cardiac monitoring for dysrhythmias
- Most patients recover within 6 days 2
Special Considerations
Co-Formulations
Pyrethroid + organophosphate mixtures (unauthorized in some countries) significantly enhance toxicity because organophosphates inhibit carboxyesterases that metabolize pyrethroids 3. If suspected:
- Treat organophosphate component with atropine and pralidoxime per standard protocols 6
- Expect prolonged and more severe pyrethroid effects
Synergists
Piperonyl butoxide (common synergist) inhibits pyrethroid metabolism, potentially increasing toxicity 2
Key Clinical Pitfalls
- Underestimating duration: Poisoning can be unexpectedly prolonged despite pyrethroids being "rapidly metabolized" 3
- Premature extubation: Laryngeal edema may not manifest until day 8+ 4
- Inadequate seizure control: Standard anticonvulsants often fail; escalate to pentobarbitone early for Type II poisoning 3
- Ignoring dermal reservoir: Skin-bound pyrethroid can cause prolonged local effects even after washing 2, 3
Consultation
Contact poison control center or medical toxicologist early, particularly for:
- Severe ingestions
- Type II pyrethroid exposures
- Co-formulated products
- Refractory seizures